Invenra, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
See more in Biomedtracker

Latest on Invenra, Inc.

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

Asia Deal Watch: Ono Calls On PRISM BioLab’s Capabilities

 
• By Lisa Takagi, Jung Won Shin, Dexter Jie Yan, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Ono Calls On PRISM For Oncology Di

Scrip

Deal Watch: Visus Begins Charting Its Direction In Ophthalmology With Two Deals

 
• By Joseph Haas, Ian Haydock, and Vibha Ravi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Visus Licenses Drugs From Cella, Delive

Scrip

Tech Transfer Roundup: Mustang, Nationwide Children’s Hospital Collaborate In Pediatric Glioblastoma

 
• By Joseph Haas

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustang